Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: Regulated by calcium independent of VEGF

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 2, 2008, Pages 649-660

  Man, Xiao Yong ^a   Yang, Xiao Hong ^a   Cai, Sui Qing ^a   Bu, Zhang Yu ^a   Zheng, Min ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Calcium; Keratinocyte; Psoriasis; VEGF; VEGFR

Indexed keywords

CALCIUM; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CELL CULTURE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMAN; KERATINOCYTE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIASIS; SKIN;

ADULT; AGED; CALCIUM; CASE-CONTROL STUDIES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PROTEINS; PSORIASIS; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; SKIN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 42349097330     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00112.x     Document Type: Article

References (39)

1. Schön MP, Boehncke WH. Psoriasis. N Engl J Med. 2005 352 : 1899 912.
2. Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol. 2005 5 : 699 711.
3. Pittelkow MR. Psoriasis: more than skin deep. Nat Med. 2005 11 : 17 8.
4. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF. Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med. 1994 180 : 1141 6.
5. Bhushan M, McLaughlin B, Weiss JB, Griffiths CE. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis. Br J Dermatol. 1999 141 : 1054 60.
6. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK. Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol. 1998 111 : 1 6.
7. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS. Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood. 2003 102 : 161 8.
8. Detmar M. Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis. J Invest Dermatol. 2004 122 : xiv - xv.
9. Young HS, Summers AM, Bhushan M, Brenchley PE, Griffiths CE. Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset. J Invest Dermatol. 2004 122 : 209 15.
10. Stacker SA, Achen MA. The vascular endothelial growth factor family: Signalling for vascular development. Growth Factors. 1999 17 : 1 11.
11. Veikkola T, Alitalo K. VEGFs, receptors and angio-genesis. Semin Cancer Biol. 1999 9 : 211 20.
12. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999 13 : 9 22.
13. Gu C, Rodriguez RE, Reimert DV, Shu T, Fritzsch B, Richards LJ, Kolodkin AL, Ginty DD. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell. 2003 5 : 45 57.
14. Wilgus TA, Matthies AM, Radek KA, Dovi JV, Burns AL, Shankar R, DiPietro LA. Novel function for vascular endothelial growth factor receptor-1 on epidermal keratinocytes. Am J Pathol. 2005 167 : 1257 66.
15. Man XY, Yang XH, Cai SQ, Yao YG, Zheng M. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Mol Med. 2006 12 : 127 36.
16. Yang XH, Man XY, Cai SQ, Yao YG, Bu ZY, Zheng M. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Biochem Biophys Res Commun. 2006 349 : 31 8.
17. ++ regulated mouse epidermal keratinocyte cultures. J Invest Dermatol. 1985 84 : 195 8.
18. Pillai S, Menon GK, Bikle DD, Elias PM. Localization and quantitation of calcium pools and calcium binding sites in cultured human keratinocytes. J Cell Physiol. 1993 154 : 101 12.
19. Hennings H, Michael D, Cheng C, Steinert PM, Holbrook K, Yuspa S. Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell. 1980 19 : 245 54.
20. Boyce ST, Ham RG. Calcium-regulated differentiation in normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial cultures. J Invest Dermatol. 1983 81 : 33 40.
21. Bruno M, Dominique B, Michel B, Caroline D, Rainer S. Influence of calcium on the proteolytic degradation of the calmodulin-like skin protein (calmodulin-like protein 5) in psoriatic epidermis. Exp Dermatol. 2006 15 : 469 77.
22. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007 8 : R19.
23. Cardones AR, Banez LL. VEGF inhibitors in cancer therapy. Curr Pharm Des. 2006 12 : 387 94.
24. Luthra S, Narayanan R, Marques LE, Chwa M, Kim DW, Dong J, Seigel GM, Neekhra A, Gramajo AL, Brown DJ, Kenney MC, Kuppermann BD. Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells. Retina. 2006 26 : 512 8.
25. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, Senger GR. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol. 1993 143 : 1255 62.
26. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev. 2004 25 : 581 611.
27. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VM, Fang GH, Dumont D, Senger DR. Expression of the fms-like tyrosine kinase FLT4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA. 1995 92 : 3566 70.
28. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K, Breitman M, Alitalo K. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998 282 : 946 9.
29. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 1998 58 : 1599 604.
30. Partanen TA, Arola J, Saaristo A, Jussila L, Ora A, Miettinen M, Achen MG, Alitalo K. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000 14 : 2087 96.
31. Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Yla-Herttuala S, Alitalo K. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med. 2001 7 : 199 205.
32. Karvonen SL, Korkiamaki T, Yla-Outinen H, Nissinen M, Teerikangas H, Pummi K, Karvonen J, Peltonen J. Psoriasis and altered calcium metabolism: downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. J Invest Dermatol. 2000 114 : 693 700.
33. Sharpe GR, Gillespie JI, Greenwell JR. An increase in intracellular free calcium is an early event during differentiation of cultured human keratinocytes. FEBS Lett. 1989 254 : 25 8.
34. Bikle DD, Ratnam A, Mauro T, Harris J, Pillai S. Changes in calcium responsiveness and handling during keratinocyte differentiation. Potential role of calcium receptor. J Clin Invest. 1996 97 : 1085 93.
35. Wang XF, Cui JZ, Prasad SS, Matsubara JA. Altered gene expression of angiogenic factors induced by calcium-mediated dissociation of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2005 46 : 1508 15.
36. Jesmin S, Sakuma I, Hattori Y, Fujii S, Kitabatake A. Long-acting calcium channel blocker benidipine suppresses expression of angiogenic growth factors and prevents cardiac remodelling in a Type II diabetic rat model. Diabetologia. 2002 45 : 402 15.
37. Diaz BV, Lenoir MC, Ladoux A, Frelin C, Demarchez M, Michel S. Regulation of vascular endothelial growth factor expression in human ker-atinocytes by retinoids. J Biol Chem. 2000 275 : 642 50.
38. Carvalho JF, Blank M, Shoenfeld Y. Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol. 2007 27 : 246 56.
39. Presta LG, Chen H, O'Connor SJ, Chisholm V, Meng YG, Krummen L, Winkler M, Ferrara N. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 1997 57 : 4593 9.